Found 4 matching trials
Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy PHASE2 This is an exploratory, open label, multi-center trial to evaluate the safe...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care PHASE1 BVAC-B is immunotherapeutic vaccine using B-Cell and Monocytes as antigen p...
Show More Location
Severance Hospital
Learn More & Join Trial
Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer PHASE1 BVAC-C is an immunotherapeutic vaccine using B-Cell and Monocytes as antige...
Show More Location
Samsung Medical Center
Learn More & Join Trial
A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. PHASE1 BVAC-E6E7 is an immunotherapeutic vaccine designed to treat unresectable re...
Show More Location
Seoul National Univesity Hospital
Learn More & Join Trial